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Abstract
Background: Presently the necessity of fasting time for coagulation tests is not standardized. Our hypothesis is that this can harm patient safety. 
This study is aimed at evaluating whether a light meal (i.e. breakfast) can jeopardize laboratory coagulation tests.
Materials and methods: A blood sample was firstly collected from 17 fasting volunteers (12 h). Immediately after blood collection, the volunteers 
consumed a light meal. Then samples were collected at 1, 2 and 4 h after the meal. Coagulation tests included: activated partial thromboplastin time 
(APTT), prothrombin time (PT), fibrinogen (Fbg), antithrombin III (AT), protein C (PC) and protein S (PS). Differences between samples were assessed 
by Wilcoxon ranked-pairs test. The level of statistical significance was set at P < 0.05. Mean % differences were determined and differences between 
and baseline and 1, 2 and 4h samples were compared with reference change value (RCV).
Results: A significantly higher % activity of AT was observed at 1 h and 4 h after meal vs. baseline specimen [113 (104-117) and 111 (107-120) vs. 
109 (102-118), respectively; P = 0.029 and P = 0.016]. APTT at 2 h was found significantly lower than baseline samples [32.0 (29.9–34.8) vs. 34.1 
(32.2-35.2), respectively; P = 0.041]. The results of both Fbg and PS tests were not influenced by a light meal. Furthermore, no coagulation tests had 
significant variation after comparison with RCV.
Conclusion: A light meal does not influence the laboratory coagulation tests we assessed, but we suggest that the laboratory quality managers 
standardize the fasting time for all blood tests at 12 hours, to completely metabolize the lipids intake.
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In the laboratory diagnostic setting, the preanalyt-
ical phase is likened to the dark side of the moon 
(i.e. as regards patient management), since many 
problems are reported, that are due to inappropri-
ate test ordering, to errors in patient identification 
and preparation, such as fasting time before sam-
ple collection, to issues in sample collection, trans-
port and delivery to the laboratory, as well as in 
sample handling and storage (1). Moreover, errors 
in preanalytical phase generate further work or 
additional investigation able to amplify both pro-
cedures sometimes unnecessary and expenditures 
for healthcare systems (2). Preanalytical issues also 
have downstream impact on the use of laboratory 
resources, hospital costs and overall quality of care (3).
The accurate investigation of haemostasis distur-
bances, either haemorrhagic or thrombotic, devel-
ops through a discretional use of laboratory re-
sources, which basically includes first and second 
line testing. First line of routine coagulation assays, 
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conventionally represented by activated partial 
thromboplastin time (APTT), prothrombin time 
(PT) and fibrinogen (Fbg), reflects the overall func-
tion of the coagulation pathway and is represent-
ed by the tests more frequently requested to 
screen for qualitative or quantitative deficiencies 
(4). The Clinical and Laboratory Standards Institute 
(CLSI) – CLSI H3-A6 document recommends to ver-
ify patient diet for restrictions and/or fasting (5). 
Moreover, this document reports relevant infor-
mation as follows: a) time and diet restrictions vary 
according to the test; b) restrictions are necessary 
to ensure accurate test results and; c) procedures 
for holding meals and notifying appropriate per-
sonnel that the patient’s blood specimen has been 
drawn should be in accordance with the institu-
tional policy. Furthermore, the CLSI H3-A6 docu-
ment does not report standardization of fasting 
time, instead leaving to the discretion of each lab-
oratory the establishment of the more appropriate 
procedures (5). The Working Group on Preanalyti-
cal Phase from European Federation of Clinical 
Chemistry and Laboratory Medicine (WG-PA EFLM) 
has provided a suitable framework for the harmo-
nization of definitions for fasting requirements for 
routine laboratory tests but not for coagulation 
tests (6). Lippi el al. showed that a light meal can 
alter the routine hematological tests (7).
Routinely outpatients go to clinical laboratories 
with pre-surgical tests requirements form; if the 
physician’s prescription contemplates lipid profile 
or glucose determination among the routine pre-
surgical tests (e.g. partial thromboplastin time, PT 
and / or Fbg concentration), the laboratory staff re-
minds the need for appropriate fasting time be-
fore blood collection, as suggested by internation-
al and local guidelines (8). Alternatively, if an out-
patient shows a test request form without associ-
ated lipid profile or glucose determinations, no 
need for fasting time appears strictly justified. Nev-
ertheless, this appears more of a habit rather than 
of a prescription based on research findings. Our 
hypothesis is that these daily practices can harm 
patient safety. This study is aimed at evaluating 




This study was conducted following the method-
ology previously published by our work group 
(7,8). A brief description follows.
A group of 17 adults of both sexes, volunteers for 
this study, from Verona (Italy), were evaluated. The 
study was submitted to the Internal Review Board, 
approved by the Human Research Ethics Commit-
tee and partially supported by CAPES Foundation, 
Ministry of Education of Brazil, Brasília - DF, Brazil 
(process number 0175-14-5). All volunteers signed 
an informed consent. The study was carried out in 
agreement with the Declaration of Helsinki.
The inclusion criteria were based on the lack of fa-
miliarity for blood coagulation disorders, platelets 
dysfunction, diabetes, dyslipidemias, thalassemia 
syndromes and other hemoglobinopathies and, in 
regards to women, that they had regular menstru-
al cycles and were not using hormonal contracep-
tives. None of the subjects took any medication. 
Body mass indices were < 30.0 kg/m2 in all sub-
jects. The light meal (i.e. 563 kcal) was based on 
commercially available meal consisting of one yo-
gurt, two slices of bread and one slice of cheese, 
chocolate snack and a fruit juice as previously de-
scribed by Lippi et al. (7)
Collection of diagnostic blood specimens
The collection of all diagnostic blood specimens 
was performed by a single, expert phlebotomist, 
following the international standard from CLSI (5,9) 
with minor modifications as previously proposed 
by our working group (10) and using transillumina-
tor device (Venoscópio IV plus, Duan do Brasil, Bra-
zil) in order to avoid the venous stasis interference 
(11). All subjects observed 15 minutes of rest be-
fore venipuncture as recommended (12). Blood 
sample collection was performed using 20 G 
straight needles from a single lot (Terumo Europe 
NV, Leuven, Belgium), directly into 3.6 mL vacuum 
tubes containing 0.4 buffered sodium citrate (9NC) 
0.109 mol/L: 3.2 W/V%, lot 1004001 (Terumo Eu-
rope NV, Leuven, Belgium). All tubes were filled at 
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their nominal volume; the first tube (i.e. without 
additive, Vacuette® lot A101004D, Greiner Bio-One 
GmbH, Kremsmünster, Austria) from each volun-
teer was draw to prevent potential bias due to con-
tact phase or tissue factor, and then processed for 
triglycerides determination. First blood sample 
was collected between 8.00 and 8.30 a.m. from 
each fasting subject (12 h, fasting time necessary 
to completely metabolize the lipids intake). Imme-
diately after blood collection, the volunteers con-
sumed a light meal (i.e. 563 kcal), containing stand-
ardized amounts of carbohydrates, protein and li-
pids. Subsequent blood samples were collected 1, 
2 and 4 hours after the end of the meal.
Processing of diagnostic blood specimens
All the sample tubes were left in upright position 
(i.e. 30 min for sodium citrate, and 60 min for se-
rum-vacuum tubes) at room temperature (i.e. 20 
ºC) to allow complete blood stability before cen-
trifugation (13). Serum tubes were centrifuged at 
2000 x g for 10 minutes, and plasma samples were 
obtained by centrifugation at 1500 x g for 15 min-
utes at room temperature (according to the in-
structions of the manufacturer). Moreover, be-
cause shortening of APTT in thawed samples may 
ensue, due to residual platelet debris in the thawed 
samples, a re-centrifugation was done and the 
platelet poor plasma (PPP) samples were then 
stored in aliquots and kept frozen at -70 ºC until 
measurement. All samples did not show any sign 
of haemolysis or lipemia by visual inspection.
Laboratory testing
All plasma aliquots frozen at -70 °C were thawed in 
water bath at 37 °C at the same time; and incubat-
ed at room temperature for 1 hour. Afterwards the 
samples were handled as fresh ones. The routine 
and specialized coagulation laboratory tests were 
performed immediately, after this incubation peri-
od, on the instrument ACL TOP (Instrumentation 
Laboratory, Milan, Italy), according to the manu-
facturer’s specifications and using HemosIL rea-
gent system (proprietary reagents). The panel of 
tests included the following: APTT (sec), PT INR, 
Fbg (g/L), antithrombin III (AT % activity), protein C 
(PC % activity) and protein S (PS % activity). The in-
strument was calibrated against appropriate pro-
prietary reference standard material and verified 
with the use of proprietary quality controls. Plas-
ma citrated samples were processed for Serum In-
dex Gen. 2® on the same Cobas 6000 <c501> mod-
ule (Roche Diagnostics GmbH, Mannheim, Germa-
ny) immediately after coagulation testing determi-
nation. Serum Index Gen. 2® is an in vitro test for 
semi-quantitative determination of the lipemia, 
haemolysis and icterus index in human serum and 
plasma on Cobas c systems (14). Because there is 
poor correlation between the lipemia index (i.e. 
corresponding to turbidity) and triglycerides con-
centration, triglycerides concentrations (mmol/L) 
were determined on the same cobas 6000 <c501> 
module using serum samples. All laboratory tests 
were performed in duplicate to minimize the ana-
lytical coefficient of variation (CVa).
Statistical analysis
The significance of differences between samples 
was assessed by Wilcoxon ranked-pairs test in 
agreement with Simundic recommendations re-
garding sample size (i.e. less than 30), using li-
censed statistical software (GraphPad Prism® ver-
sion 5.01, La Jolla, CA, USA) (15). The level of statis-
tical significance was set at P < 0.05. The clinically 
significant change in consecutive results from an 
individual, taking into consideration both analyti-
cal and biological variations, was calculated for 
each test using the reference change value (RCV) 
equation as follows:
RCV = 21/2 x Z x (CVW2 + CVA2)1/2,
where: Z is a constant depending on the probabil-
ity, where 1.96 is most often used as significant, 
that is, P < 0.05; CVw is the within-subject biologi-
cal variation obtained from Westgard database 
(16); and CVa is the analytical coefficient of varia-
tion from our internal quality control. Mean % dif-
ferences were determined according to the formu-
la:
mean % difference = [(x h after meal – baseline) / 
x h after meal] x 100%.
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Finally, the mean % difference from 1, 2 and 4 hours 
after intake of a standardised meal were compared 
with RCV. Only mean % differences higher than RCV 
were considered clinically significant. Desirable 
specification for imprecision (DSI) derived from bio-
logic variation (16) was used as our criteria of ac-
ceptance in lipemia analytical interference testing.
Results
The results of this investigation are presented as 
median (interquartile range) in Table 1. We found a 
significantly higher % activity of AT in 1 h and 4 h 
after the ingestion of the light meal as compared 
to baseline specimen [113 (104-117) and 111 (107-
120) vs. 109 (102-118), respectively; P = 0.029 and P 
= 0.016]. Two hours after the ingestion of the meal, 
APTT was found significantly lower than baseline 
samples [32.0 (29.9-34.8) vs. 34.1 (32.2-35.2), re-
spectively; P = 0.041]. The results of both Fbg and 
PS tests appeared not influenced by a light meal. 
Furthermore, no coagulation tests had shown clin-
ically significant variation after comparison with 
RCV. Lipemia analytical interference testing was 
observed for APTT, PT, AT and PC, after compari-
son with DSI derived from biologic variation (Fig-
ure 1). The results of both Fbg and PS tests ap-
peared not influenced by a light meal. Further-
more, no coagulation tests had shown clinically 
significant variation after comparison with RCV.
Discussion
Our results have shown that a light meal is able to 
statistically modify the APTT and AT. Instrumenta-
tion Laboratory reagents manufacturer’s declara-
tion notify that ACL TOP Family System are not af-
fected by triglycerides up to: 11.3 mmol/L for both 
APTT and PT, 9.9 mmol/L for Fbg, 26.0 mmol/L for 


































































































index NA NA NA NA 9 (8-14) 14 (11-20) 35.7 0.001* 16 (11-18) 43.8 < 0.001* 13 (12-16) 30.8 0.003*
Hemolysis 
index NA NA NA NA 3 (2-4) 3 (2-4) 0 0.987 3 (2-4) 0 0.992 3 (2-4) 0 0.998
Results are presented as median (interquartile range). *Statistically significant difference (P < 0.05).
APTT - activated partial thromboplastin time; PT - prothrombin time; Fbg – fibrinogen; AT - antithrombin III; PC - protein C; PS - 
protein S; NA - not applicable; Tg – triglycerides; CVa - analytical coefficient of variation; CVw - within-subject biological variation; RCV 
- reference change value; DSI - desirable specification for imprecision derived from biologic variation.
Table 1. Postprandial variation on coagulation tests after meal.
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Figure 1. Lipemia interferograms for (A) APTT, (B) PT, (C) AT, (D) PC, (E) PS, (F) Fbg.
Hours after light meal (x-axis) are plotted against bias values (y-axis). Solid line – bias. Dashed lines - acceptable criteria based on 
desirable specification for imprecision (DSI) derived from biologic variation.
APTT - activated partial thromboplastin time; PT - prothrombin time; AT - antithrombin III; PC - protein C; PS - protein S; FbG - fibrino-
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Furthermore, our results have shown that the in-
fluence of lipemia was seriously underestimated, 
meaning that the measured bias at declared trig-
lycerides concentration was higher than reported 
by the manufacturer for APTT, PT, AT and PC. The 
concentration of triglycerides in our samples was 
lower than 2.0 mmol/L. Obviously the quality spec-
ifications derived from biological variation (17) are 
considered both very important and useful in the 
daily practice by the quality managers of the med-
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ical laboratories (16,18). Moreover, Nikolac et al. 
properly proposed that manufacturers should use 
evidence based quality specifications for assessing 
the allowable biases, instead of arbitrary limits (19). 
Because no coagulation test showed clinically sig-
nificant variation after comparison with RCV, the 
light meal does not appear able to cause relevant 
changes on coagulation test results, also if the an-
alytical bias was higher than specified. Thus, no 
consequences of inadequate fasting time observ-
ance are to be expected and no interference with 
the decisions of the caring physicians unaware of 
the real patient situation can ensue.
Presently many procedures are performed and/or 
oriented by non-laboratory professionals (e.g. 
nurses, non-technician personnel and administra-
tive staff) (20). Moreover, poor control and stand-
ardization of the preanalytical phase in the whole 
testing process may influence the reliability of co-
agulation testing in the following points: i) phle-
botomy procedure (21-23); ii) venous stasis (11,24): 
iii) vacuum tube used for blood collection by veni-
puncture (25). Instead, some procedures regarding 
the order of draw and mixing of primary blood 
tubes after collection by vacuum systems seem 
unimportant (26-29). In fact, the influence of light 
meal on coagulation testing was never evaluated 
before as reported in our protocol.
A limitation of our study design was the enrolment 
of a rather small number of apparently healthy vol-
unteers. In any case, no substantial differences af-
ter a light meal were observed in this longitudinal 
study. Nevertheless, in order to increase the sensi-
tivity of this finding, further research on individu-
als with blood clotting disorders might be needed 
to confirm the above outcomes.
Conclusion
It is clear that a light meal does not jeopardize the 
laboratory coagulation tests we assessed, but we 
strongly suggest that the laboratory quality man-
agers standardize the fasting time for all blood 
tests at 12 hours, i.e. the fasting time necessary to 
completely metabolize the lipids intake. This kind 
of standardization could prevent possible labora-
tory variability that was not evaluated in our study 
(i.e. more caloric food intake as lunch or dinner) 
and unpredictable analytical bias.
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